Subcostal Transversus Abdominis Plane Versus Epidural Block in Abdominal Surgeries
Comparative Study Between Subcostal Transversus Abdominis Plane Block Analgesia and Epidural Analgesia in Upper Abdominal Surgeries
1 other identifier
interventional
84
1 country
1
Brief Summary
The investegators aimed to compare the efficacy of subcostal Transversus abdominis plane analgesia, to epidural analgesia intra and postoperatively in upper abdominal surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2019
CompletedStudy Start
First participant enrolled
May 10, 2019
CompletedFirst Posted
Study publicly available on registry
May 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedSeptember 11, 2020
May 1, 2019
6 months
May 8, 2019
September 9, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Total morphine consumption
Intravenous morphine in adose of 0.05 mg/kg will be given if Visual Analogue Scale (VAS) is more than 30 mm in both groups and can be repeated every 15 minutes till Visual Analogue Scale become less than 3. Morphine administration will be ceased when the Visual Analogue Scale score \<30 mm on assessment or when over-sedation or respiratory depression occurred (a respiratory rate of \< 10 bpm). Doses given will be calculated daily and recorded.
For 72 hours after surgery
Secondary Outcomes (10)
First request for rescue analgesia
for 72 hours after surgery
Pain Scores
up to 72 hours postoperatively
Heart rate
for 72 hours postoperative
Mean arterial blood pressure
for 72 hours postoperative
Peripheral oxygen saturation
for 72 hours postoperative
- +5 more secondary outcomes
Study Arms (2)
Subcostal Transversus Abdominis Plane catheter
ACTIVE COMPARATORThis group includes patients who will receive subcostal Transversus abdominis plane block analgesia
Epidural catheter
PLACEBO COMPARATORThis group includes patients who will receive epidural analgesia using a catheter technique
Interventions
Prior to surgery, an ultrasound guided unilateral Subcostal Transversus abdominis plane bolus dose (consisting of amixture of 10 ml bupivaccaine 0.5% plus 100 mg magnesium sulphate to be completed by normal saline to a total volume of 20 ml mixture) will be given on the same side of the surgical incision. At the end of surgery, A Transversus abdominis plane catheter will be inserted unilaterally by surgeon during wound closure. Then postoperatively, Transversus abdominis plane infusion of a solution mixture prepared in multiple 50 cm syringes each syringe contain 20 ml bupivacaine 0.5% plus 100 mg magnesium sulphate to be balanced by normal saline to 50 ml solution mixture ( final concentration of bupivacaine is 0.2%). This solution mixture will be infused through Transversus abdominis plane catheter at a rate of 6 ml/hour for 72 hours postoperatively.
Prior to surgery, we will site an epidural catheter in the thoracic T7-T9 region, and inject an epidural bolus dose same as described above (consisting of amixture of 10 ml bupivaccaine 0.5% plus 100 mg magnesium sulphate to be completed by normal saline to a total volume of 20 ml mixture) for intra operative analgesia. Postoperatively, patients will receive epidural infusion of the solution mixture (same as described above) prepared in multiple 50 cm syringes each syringe contain 20 ml bupivaccaine 0.5% plus 100 mg magnesium sulphate to be balanced by normal saline to 50 ml solution mixture ( final concentration of bupivaccaine is 0.2%). This solution mixture will be infused epidurally at a rate of 6 ml/hour for 72 hours (3 days) postoperatively.
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists (ASA) physical status I, II or III
- The incision included is right subcostal incision for major upper abdominal surgeries (partial hepatectomy, pancreatic surgery included Whipple's procedure, total pancreatectomy and distal pancreatectomy) and other operations using the same incision.
You may not qualify if:
- Patient refusal.
- Hematological diseases.
- Bleeding diseases.
- Coagulation abnormality.
- Local skin infection
- Sepsis at site of the block.
- Known hypersensitivity to the study drugs.
- Body Mass Index \> 35 Kg/m2.
- If the lower end of the incision extended below T10 (umbilicus).
- If the incision extended laterally beyond the anterior axillary line or extended to pass the midline to the other side.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mansoura University
Al Mansurah, DK, 050, Egypt
Related Publications (2)
Hebbard P. Subcostal transversus abdominis plane block under ultrasound guidance. Anesth Analg. 2008 Feb;106(2):674-5; author reply 675. doi: 10.1213/ane.0b013e318161a88f. No abstract available.
PMID: 18227342RESULTCulebras X, Van Gessel E, Hoffmeyer P, Gamulin Z. Clonidine combined with a long acting local anesthetic does not prolong postoperative analgesia after brachial plexus block but does induce hemodynamic changes. Anesth Analg. 2001 Jan;92(1):199-204. doi: 10.1097/00000539-200101000-00038.
PMID: 11133627RESULT
Study Officials
- STUDY CHAIR
Mohamed Y Makharita, MD
Professor of Anesthesia and Surgical Intensive Care
- STUDY DIRECTOR
Hazem ES Moawad, MD
Assistant Professor of Anesthesia and Surgical Intensive Care
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 8, 2019
First Posted
May 14, 2019
Study Start
May 10, 2019
Primary Completion
November 1, 2019
Study Completion
January 1, 2020
Last Updated
September 11, 2020
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- data will be available within 6 monthes of study completion.
- Access Criteria
- Data may be shared by contacting the principle investegator.
De-identified individual participant data for all primary and secondary outcome measures will be made available